4.7 Article

Mutations underlying Episodic Ataxia type-1 antagonize Kv1.1 RNA editing

Journal

SCIENTIFIC REPORTS
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep41095

Keywords

-

Funding

  1. Vanderbilt Molecular Endocrinology Training Program [T32DK007563]
  2. Ruth L. Kirschstein National Research Service Award [F31NS087911]
  3. Vanderbilt Dissertation Enhancement Grant
  4. Vanderbilt Joel G. Hardman Chair in Pharmacology
  5. NINDS [R0111223855, R01NS64259]
  6. Cystic Fibrosis Foundation Therapeutics [Rosent14XXO]

Ask authors/readers for more resources

Adenosine-to-inosine RNA editing in transcripts encoding the voltage-gated potassium channel Kv1.1 converts an isoleucine to valine codon for amino acid 400, speeding channel recovery from inactivation. Numerous Kv1.1 mutations have been associated with the human disorder Episodic Ataxia Type-1 (EA1), characterized by stress-induced ataxia, myokymia, and increased prevalence of seizures. Three EA1 mutations, V404I, I407M, and V408A, are located within the RNA duplex structure required for RNA editing. Each mutation decreased RNA editing both in vitro and using an in vivo mouse model bearing the V408A allele. Editing of transcripts encoding mutant channels affects numerous biophysical properties including channel opening, closing, and inactivation. Thus EA1 symptoms could be influenced not only by the direct effects of the mutations on channel properties, but also by their influence on RNA editing. These studies provide the first evidence that mutations associated with human genetic disorders can affect cis-regulatory elements to alter RNA editing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available